Hanik Kholidah
- blocking
- depression
- June 14, 2026
- 0 Comments
New Research Suggests Blocking Inflammatory Pathways May Be Key to Treating Resistant Depression through Targeted Immune Modulation
For decades, the prevailing paradigm in clinical psychiatry has centered on the "monoamine hypothesis," which suggests that depression is primarily a result of chemical imbalances in the brain involving neurotransmitters…
